Cargando…
Pharmacokinetics of gene recombined angiogenesis inhibitor Kringle 5 in vivo using (131)I specific markers and SPECT/CT()
The previous pharmacokinetic methods can be only limited to drug analysis in vitro, which provide less information on the distribution and metabolismof drugs, and limit the interpretation and assessment of pharmacokinetics, the determination of metabolic principles, and evaluation of treatment effec...
Autores principales: | Yan, Ge, Yang, Danrong, Yu, Yan, Xue, Jianjun, Jia, Yifan, Sun, Xuanzi, Wang, Boyu, Zhao, Zewei, Wang, Maode |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Xi'an Jiaotong University
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762626/ https://www.ncbi.nlm.nih.gov/pubmed/29403998 http://dx.doi.org/10.1016/j.jpha.2016.09.001 |
Ejemplares similares
-
Iodine-131MIBG SPECT/CT in neuroendocrine tumours: An institutional experience
por: Verma, Priyanka, et al.
Publicado: (2012) -
Miguel Llinás and the Structure of the Kringle Fold
por: Patthy, Laszlo
Publicado: (2021) -
The angiogenesis inhibitor protease-activated kringles 1–5 reduces the severity of murine collagen-induced arthritis
por: Sumariwalla, Percy F, et al.
Publicado: (2003) -
(131)I-labeled polyethylenimine-entrapped gold nanoparticles for targeted tumor SPECT/CT imaging and radionuclide therapy
por: Sun, Na, et al.
Publicado: (2019) -
Assessment of mouse-specific pharmacokinetics in kidneys based on (131)I activity measurements using micro-SPECT
por: Vargas, Clarita Saldarriaga, et al.
Publicado: (2022)